Cerivastatin, an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, Inhibits Endothelial Cell Proliferation Induced by Angiogenic Factors In Vitro and Angiogenesis in In Vivo Models
- 1 April 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 22 (4) , 623-629
- https://doi.org/10.1161/01.atv.0000012283.15789.67
Abstract
Cerivastatin is an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. It inhibits the biosynthesis of cholesterol and its precursors: farnesyl pyrophosphate and geranylgeranyl pyrophosph...Keywords
This publication has 23 references indexed in Scilit:
- A family outing: small GTPases cyclin' through G1Nature Cell Biology, 2001
- RhoA Prenylation Is Required for Promotion of Cell Growth and Transformation and Cytoskeleton Organization but Not for Induction of Serum Response Element TranscriptionJournal of Biological Chemistry, 2000
- Isoprenoid-Mediated Inhibition of Mevalonate Synthesis: Potential Application to CancerExperimental Biology and Medicine, 1999
- Mechanisms modifying atherosclerotic disease — from lipids to vascular biologyAtherosclerosis, 1999
- Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules.Journal of Clinical Investigation, 1997
- Integrin-mediated signalling: regulation by protein tyrosine kinases and small GTP-binding proteinsCurrent Opinion in Cell Biology, 1996
- Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospectsJournal of Molecular Medicine, 1995
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- A geranylgeranyltransferase for rhoA p21 distinct from the farnesyltransferase for ras p21ABiochemical and Biophysical Research Communications, 1991
- The possible role of the arterial microcirculation in the pathogenesis of atherosclerosisJournal of Chronic Diseases, 1980